# A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules

> **NCT02310022** · PHASE1,PHASE2 · COMPLETED · sponsor: **Matinas Biopharma, Inc** · enrollment: 48 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** Drug Omega 3
- **DRUG:** Drug Omega-3 Comparator

## Key facts

- **NCT ID:** NCT02310022
- **Lead sponsor:** Matinas Biopharma, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-05
- **Final completion:** 2016-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02310022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02310022, "A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02310022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*